{"id":4042,"date":"2017-08-13T11:10:59","date_gmt":"2017-08-13T11:10:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/2nd-world-congress-integrative-medicine\/"},"modified":"2026-02-17T12:09:34","modified_gmt":"2026-02-17T12:09:34","slug":"congress-integrative-medicine-hyperthermia","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/sv\/congress-integrative-medicine-hyperthermia\/","title":{"rendered":"2:a v\u00e4rldskongressen Integrativ medicin &#8211; l\u00e4kare G. Fiorentini onkologi Ph.D. &#8211; presentation hypertermi"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/sv\/congress-integrative-medicine-hyperthermia\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/sv\/congress-integrative-medicine-hyperthermia\/\",\n      \"name\": \"Prof. Dr. Giammaria Fiorentini: Globalt vetenskapligt ledarskap & mHT-studier\",\n      \"description\": \"Utforska den kliniska portf\u00f6ljen och mHT-forskningen (modulerad elektrohypertermi) av Prof. Dr. Giammaria Fiorentini. Multicenterstudier om bukspottk\u00f6rtelcancer och glioblastom.\",\n      \"inLanguage\": \"sv-SE\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"publisher\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/sv\/congress-integrative-medicine-hyperthermia\/#fiorentini\" },\n      \"about\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/sv\/congress-integrative-medicine-hyperthermia\/#fiorentini\" },\n        { \"@type\": \"MedicalProcedure\", \"name\": \"Modulerad elektrohypertermi (mHT)\" }\n      ]\n    },\n    {\n      \"@type\": \"Person\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/sv\/congress-integrative-medicine-hyperthermia\/#fiorentini\",\n      \"name\": \"Prof. Dr. Giammaria Fiorentini\",\n      \"jobTitle\": \"Ledamot i vetenskapliga r\u00e5det (SRHO & SIIO), ESHO-medlem\",\n      \"sameAs\": [\n        \"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fiorentini+G\",\n        \"https:\/\/scholar.google.com\/scholar?q=Giammaria+Fiorentini\"\n      ],\n      \"knowsAbout\": [\"Onkologisk hypertermi\", \"Integrativ onkologi\", \"Klinisk mHT-forskning\"],\n      \"workExample\": [\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"Hypertermi kombinerad med kemoterapi vs. enbart kemoterapi hos patienter med avancerad bukspottk\u00f6rtelcancer (2023)\",\n          \"identifier\": \"PMID: 37398545\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"Modulerad elektrohypertermi vid stadium III och IV bukspottk\u00f6rtelcancer: Resultat fr\u00e5n 158 patienter (2021)\",\n          \"identifier\": \"PMID: 34909400\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"mHT i integrativ cancerbehandling f\u00f6r recidiverande malignt glioblastom och astrocytom (2019)\",\n          \"identifier\": \"PMID: 30580645\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"Quo Vadis onkologisk hypertermi? (2020)\",\n          \"identifier\": \"PMID: 33014841\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"En klinisk fas II-studie om recidiverande maligna gliom behandlade med elektrohypertermi (2006)\",\n          \"identifier\": \"PMID: 17203754\"\n        },\n        {\n          \"@type\": \"MedicalScholarlyArticle\",\n          \"name\": \"Modulerad elektrohypertermi som palliativ behandling: Analys av 106 patienter (2019)\",\n          \"identifier\": \"PMID: 31561722\"\n        }\n      ]\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/\",\n      \"logo\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/Andromedic-Logo.jpg\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">Global excellens inom integrativ onkologi: ICIM Rom 2023<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">Vetenskapligt samarbete med prof. dr. Giammaria Fiorentini<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\">Teamet fr\u00e5n <strong>Imunomedica<\/strong> (dr. Virgiliu Vlaescu George, <a style=\"color: #1a2a6c; text-decoration: underline;\" href=\"https:\/\/andromedichyperthermia.com\/cristian-gologan\/\">Cristian Gologan M.Sc.<\/a>, <a style=\"color: #1a2a6c; text-decoration: underline;\" href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-veronica-iatan\/\">dr. Veronica Iatan<\/a>, dr. Laurentiu Broscaru) deltog i den 2:a v\u00e4rldskongressen f\u00f6r integrativ medicin och konsoliderade protokoll f\u00f6r onkologisk hypertermi p\u00e5 h\u00f6gsta globala niv\u00e5.<\/p>\n<\/header>\n<div style=\"display: flex; flex-wrap: wrap; justify-content: center; gap: 20px; margin-bottom: 50px; background: linear-gradient(135deg, #1a2a6c, #b21f1f); padding: 35px; border-radius: 15px; color: #fff; text-align: center; box-shadow: 0 10px 25px rgba(0,0,0,0.15);\">\n<div style=\"flex: 1; min-width: 200px;\"><span style=\"font-size: 45px; font-weight: 800; display: block;\">357<\/span><span style=\"text-transform: uppercase; font-size: 13px; letter-spacing: 1.5px; font-weight: 600;\">PubMed-studier<\/span><\/div>\n<div style=\"flex: 1; min-width: 200px;\"><span style=\"font-size: 45px; font-weight: 800; display: block;\">20+<\/span><span style=\"text-transform: uppercase; font-size: 13px; letter-spacing: 1.5px; font-weight: 600;\">Behandlade cancerformer<\/span><\/div>\n<div style=\"flex: 1; min-width: 200px;\"><span style=\"font-size: 45px; font-weight: 800; display: block;\">ESHO<\/span><span style=\"text-transform: uppercase; font-size: 13px; letter-spacing: 1.5px; font-weight: 600;\">Medicinsk elitexpertis<\/span><\/div>\n<\/div>\n<div style=\"display: flex; flex-direction: column; align-items: center; gap: 30px; margin-bottom: 50px;\">\n<div style=\"width: 100%; max-width: 850px; text-align: center;\">\n<p><img loading=\"lazy\" decoding=\"async\" width=\"799\" height=\"571\" class=\"wp-image-502\" style=\"width: 100%; border-radius: 15px; box-shadow: 0 8px 20px rgba(0,0,0,0.1);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023.jpg\" alt=\"Imunomedica-teamet i Rom 2023 \u2013 onkologisk hypertermi\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023.jpg 799w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023-300x214.jpg 300w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/icim-2023-768x549.jpg 768w\" sizes=\"auto, (max-width: 799px) 100vw, 799px\" \/><\/p>\n<p style=\"font-size: 14px; color: #666; margin-top: 10px; font-style: italic;\">Certifiering f\u00f6r klinisk expertis inom hypertermi \u2013 Cristian Gologan M.Sc.<\/p>\n<\/div>\n<div style=\"width: 100%; max-width: 850px; text-align: center;\">\n<p><img decoding=\"async\" class=\"wp-image-503\" style=\"width: 100%; border-radius: 15px; box-shadow: 0 8px 20px rgba(0,0,0,0.1);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/2nd-world-congress-of-integrative-medicine-and-health-rome-2023.jpg\" alt=\"Den 2:a v\u00e4rldskongressen i Rom 2023\" title=\"\"><\/p>\n<p style=\"font-size: 14px; color: #666; margin-top: 10px; font-style: italic;\">ICIM Rom plenumsession \u2013 Framtiden f\u00f6r integrativ onkologisk medicin.<\/p>\n<\/div>\n<\/div>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; padding: 35px; border-radius: 15px; background-color: #f9f9f9;\">\n<h3 style=\"color: #1a2a6c; border-bottom: 3px solid #b21f1f; display: inline-block; padding-bottom: 5px; margin-bottom: 20px;\">Globalt vetenskapligt ledarskap<\/h3>\n<p style=\"font-size: 17px; margin-bottom: 20px;\"><strong>Prof. dr. Giammaria Fiorentini<\/strong> \u00e4r en framst\u00e5ende medlem i <a style=\"color: #b21f1f; text-decoration: none; font-weight: bold;\" href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO (European Society for Hyperthermic Oncology)<\/a> och aktiv i det vetenskapliga r\u00e5det (SAB) f\u00f6r <strong>SRHO<\/strong> och <strong>SIIO<\/strong>. V\u00e5rt direkta samarbete garanterar patienter tillg\u00e5ng till kliniska resultat validerade av fler \u00e4n 350 publicerade artiklar.<\/p>\n<div style=\"background: #1a2a6c; padding: 20px; border-radius: 10px; text-align: center;\"><a style=\"color: #fff; text-decoration: none; font-weight: 800; font-size: 18px;\" href=\"http:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/WS-G-Giorentini-20-sept-2023-room-9-Rome-hyperthermia-x-gologan.pdf\"> LADDA NED: Klinisk \u00f6versikt och fallrapporter (PDF)<\/a><\/div>\n<\/section>\n<div style=\"background: #f0f4f8; padding: 30px; border-radius: 15px; margin-bottom: 50px; text-align: center; border: 1px solid #d1d9e6;\">\n<h4 style=\"color: #1a2a6c; margin-bottom: 25px; text-transform: uppercase;\">Verkningsmekanism dokumenterad i Fiorentinis forskning<\/h4>\n<div style=\"display: flex; flex-wrap: wrap; justify-content: space-around; align-items: center; gap: 20px; margin-top: 20px;\">\n<div style=\"flex: 1; min-width: 250px; background: #fff; padding: 20px; border-radius: 10px; border-top: 5px solid #b21f1f;\">\n<p><span style=\"font-size: 24px; display: block; margin-bottom: 10px;\"> 13.56 MHz<\/span><\/p>\n<p style=\"font-size: 14px; margin: 0;\"><b>Selektivitet:<\/b> Radiov\u00e5gor identifierar maligna celler p\u00e5 grund av deras h\u00f6ga elektriska ledningsf\u00f6rm\u00e5ga.<\/p>\n<\/div>\n<div style=\"flex: 1; min-width: 250px; background: #fff; padding: 20px; border-radius: 10px; border-top: 5px solid #b21f1f;\">\n<p><span style=\"font-size: 24px; display: block; margin-bottom: 10px;\"> Termisk stress<\/span><\/p>\n<p style=\"font-size: 14px; margin: 0;\"><b>Apoptos:<\/b> Riktad v\u00e4rme inducerar destruktion av cancerceller utan att p\u00e5verka frisk v\u00e4vnad.<\/p>\n<\/div>\n<div style=\"flex: 1; min-width: 250px; background: #fff; padding: 20px; border-radius: 10px; border-top: 5px solid #b21f1f;\">\n<p><span style=\"font-size: 24px; display: block; margin-bottom: 10px;\">&#xfe0f; Immunitet<\/span><\/p>\n<p style=\"font-size: 14px; margin: 0;\"><b>Abskopal effekt:<\/b> F\u00f6rbereder immunsystemet p\u00e5 att k\u00e4nna igen och angripa systemiska maligna celler.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<h3 style=\"color: #1a2a6c; border-left: 6px solid #b21f1f; padding-left: 15px; margin-bottom: 30px;\">Viktiga kliniska referenser: prof. Giammaria Fiorentini<\/h3>\n<div style=\"display: grid; grid-gap: 20px;\">\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #fff; border-top: 4px solid #b21f1f;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2023] Hypertermi kombinerat med kemoterapi vs. kemoterapi hos patienter med avancerad bukspottk\u00f6rtelcancer.<\/strong><\/p>\n<p style=\"font-size: 15px;\">En multicenterstudie som visar en \u00f6kning av median\u00f6verlevnaden fr\u00e5n 9 till 20 m\u00e5nader genom integrering av mHT.<\/p>\n<p><small style=\"color: #666;\"><strong>F\u00f6rfattare: Fiorentini G<\/strong>, et al. | World J Clin Oncol. PMID: 37398545<\/small><\/p>\n<\/div>\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #fff; border-top: 4px solid #b21f1f;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2021] Modulerad elektro-hypertermi vid bukspottk\u00f6rtelcancer stadium III och IV: resultat hos 158 patienter.<\/strong><\/p>\n<p style=\"font-size: 15px;\">Observationsanalys av en av de st\u00f6rsta patientkohorterna, vilket bekr\u00e4ftar tum\u00f6rkontroll i avancerade stadier.<\/p>\n<p><small style=\"color: #666;\"><strong>F\u00f6rfattare: Fiorentini G<\/strong>, et al. | World J Clin Oncol. PMID: 34909400<\/small><\/p>\n<\/div>\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #fff; border-top: 4px solid #b21f1f;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2019] mHT i integrativ cancerbehandling f\u00f6r recidiverande malignt glioblastom och astrocytom.<\/strong><\/p>\n<p style=\"font-size: 15px;\">Kontrollerad multicenterstudie p\u00e5 patienter med hj\u00e4rnrecidiv, som validerar s\u00e4kerhet och livsf\u00f6rl\u00e4ngning.<\/p>\n<p><small style=\"color: #666;\"><strong>F\u00f6rfattare: Fiorentini G<\/strong>, et al. | Integr Cancer Ther. PMID: 30580645<\/small><\/p>\n<\/div>\n<div style=\"padding: 20px; border: 1px solid #e1e8ed; border-radius: 8px; background: #f4f7f9; border-top: 4px solid #1a2a6c;\">\n<p><strong style=\"font-size: 17px; display: block; margin-bottom: 10px;\">[2020] Quo Vadis onkologisk hypertermi?<\/strong><\/p>\n<p style=\"font-size: 15px;\">En banbrytande \u00f6versikt som redefinierar onkologisk hypertermi och betonar den nanoskopiska selektiviteten hos maligna celler.<\/p>\n<p><small style=\"color: #666;\"><strong>Medf\u00f6rfattare: Fiorentini G<\/strong> | Front Oncol. PMID: 33014841<\/small><\/p>\n<\/div>\n<\/div>\n<div style=\"text-align: center; margin-top: 40px; padding: 25px; border: 2px dashed #1a2a6c; border-radius: 10px; background-color: #fcfcfc;\">\n<p style=\"font-weight: bold; margin-bottom: 15px;\">Utforska Fiorentinis fullst\u00e4ndiga forskningsportf\u00f6lj:<\/p>\n<p><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fiorentini+G\" target=\"_blank\" rel=\"noopener\">VISA ALLA 357 RESULTAT P\u00c5 PUBMED<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Global excellens inom integrativ onkologi: ICIM Rom 2023 Vetenskapligt samarbete med prof. dr. Giammaria Fiorentini Teamet fr\u00e5n Imunomedica (dr. Virgiliu Vlaescu George, Cristian Gologan M.Sc., dr. Veronica Iatan, dr. Laurentiu Broscaru) deltog i den 2:a v\u00e4rldskongressen f\u00f6r integrativ medicin och konsoliderade protokoll f\u00f6r onkologisk hypertermi p\u00e5 h\u00f6gsta globala niv\u00e5. 357PubMed-studier 20+Behandlade cancerformer ESHOMedicinsk elitexpertis Certifiering&hellip;<\/p>\n","protected":false},"author":1,"featured_media":2540,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-4042","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/pages\/4042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/comments?post=4042"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/pages\/4042\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/media\/2540"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/sv\/wp-json\/wp\/v2\/media?parent=4042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}